RedHill Biopharma Reports Operational Highlights and Fourth Quarter & Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
RedHill Biopharma (RDHL) Reports Q4 Operating Loss of $20.7M
March 17, 2022 8:04 AM EDTRedHill Biopharma (NASDAQ: RDHL) reported Q4 operating loss of $20.7 million. Revenue for the quarter came in at $22.1 million versus the consensus estimate of $24.08 million.
For earnings history and earnings-related data on RedHill Biopharma (RDHL) click here.
... More